EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Clinical and Epidemiologic Features of Cryptosporidium- Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study

M Jahangir Hossain, Helen Powell, Samba O Sow, Richard Omore, Anna Roose, Joquina Chiquita M Jones, Syed M A Zaman, Henry Badji, Golam Sarwar, Irene N Kasumba, Uma Onwuchekwa, Sanogo Doh und 12 weitere

Clinical Infectious Diseases · 19.04.2023 · 76 (Supplement_1) · S97-S105

DOI: 10.1093/cid/ciad044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, online erschienen am 19.04.2023. Verfasst von M Jahangir Hossain und 23 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia. Hauptthemen laut MEDLINE: Cryptosporidium, Cryptosporidiosis, Rotavirus Vaccines. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bill & Melinda Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

As part of the Vaccine Impact on Diarrhea in Africa (VIDA) Study, we examined the prevalence, clinical presentation, and seasonality of Cryptosporidium in children to understand its relative burden after the introduction of rotavirus vaccine.

Methods

VIDA was a 3-year, age-stratified, matched case-control study of medically attended acute moderate-to-severe diarrhea (MSD) in children aged 0–59 months residing in censused populations at sites in Kenya, Mali, and The Gambia. Clinical and epidemiologic data were collected at enrollment, and a stool sample was tested for enteropathogens by quantitative PCR. An algorithm was created based on the organism's cycle threshold (Ct) and association with MSD to identify the subset of Cryptosporidium PCR-positive (Ct <35) cases most likely to be attributed to MSD. Clinical outcomes were assessed at 2–3 months after enrollment.

Results

One thousand one hundred six (22.9%) cases of MSD and 873 controls (18.1%) were PCR positive for Cryptosporidium; 465 cases (42.0%) were considered attributable to Cryptosporidium, mostly among children 6–23 months. Cryptosporidium infections peaked in The Gambia and Mali during the rainy season, while in Kenya they did not have clear seasonality. Compared with cases with watery MSD who had a negative PCR for Cryptosporidium, cases with watery MSD attributed to Cryptosporidium were less frequently dehydrated but appeared more severely ill using a modified Vesikari scale (38.1% vs 27.0%; P < 0.001), likely due to higher rates of hospitalization and intravenous fluid administration, higher prevalence of being wasted or very thin very thin (23.4% vs 14.7%; P < 0.001), and having severe acute malnutrition (midupper arm circumference <115 mm, 7.7% vs 2.5%; P < 0.001). On follow-up, Cryptosporidium-attributed cases had more prolonged and persistent episodes (43.2% vs 32.7%; P <0 .001) and linear growth faltering (change in height-for-age z score between enrollment and follow-up: −0.29 vs −0.17; P < 0.001).

Conclusions

The burden of Cryptosporidium remains high among young children in sub-Saharan Africa. Its propensity to cause illness and further impact children longer term by compromising nutritional status early in life calls for special attention to enable appropriate management of clinical and nutritional consequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CryptosporidiumCryptosporidiosisRotavirus VaccinesHumansChildInfantChild, PreschoolCase-Control StudiesDiarrheaKenya

Stichwörter der Autor:innen

Cryptosporidiumchildrendiarrheaprevalenceseverity

Substanzen

Rotavirus Vaccines

Autor:innen und Institutionen

  • Medical Research Council Unit, The Gambia at the London School of Hygiene & Tropical Medicine, Banjul, The Gambia.
  • Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Centre pour le Développement des Vaccins du Mali (CVD-Mali), Bamako, Mali.
  • Center for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya.
  • Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Förderung

  • Bill & Melinda Gates Foundation

Zitieren

APA

Hossain, M. J., Powell, H., Sow, S. O., Omore, R., Roose, A., Jones, J. C. M., Zaman, S. M. A., Badji, H., Sarwar, G., Kasumba, I. N., Onwuchekwa, U., Doh, S., Awuor, A. O., Ochieng, J. B., Verani, J. R., Liu, J., Tennant, S. M., Nasrin, D., Jamka, L. P., …, & Kotloff, K. L. (2023). Clinical and Epidemiologic Features of Cryptosporidium- Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study. Clinical Infectious Diseases, 76(Supplement_1), S97-S105. https://doi.org/10.1093/cid/ciad044

Vancouver

Hossain MJ, Powell H, Sow SO, Omore R, Roose A, Jones JCM, et al. Clinical and Epidemiologic Features of Cryptosporidium- Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study. Clinical Infectious Diseases. 2023;76(Supplement_1):S97-S105. doi:10.1093/cid/ciad044

BibTeX
@article{Hossain2023,
  author = {Hossain, M Jahangir and Powell, Helen and Sow, Samba O and Omore, Richard and Roose, Anna and Jones, Joquina Chiquita M and Zaman, Syed M A and Badji, Henry and Sarwar, Golam and Kasumba, Irene N and Onwuchekwa, Uma and Doh, Sanogo and Awuor, Alex O and Ochieng, John B and Verani, Jennifer R and Liu, Jie and Tennant, Sharon M and Nasrin, Dilruba and Jamka, Leslie P and Liang, Yuanyuan and Howie, Stephen R C and Antonio, Martin and Houpt, Eric R and Kotloff, Karen L},
  title = {Clinical and Epidemiologic Features of Cryptosporidium- Associated Diarrheal Disease Among Young Children Living in Sub-Saharan Africa: The Vaccine Impact on Diarrhea in Africa (VIDA) Study},
  journal = {Clinical Infectious Diseases},
  year = {2023},
  volume = {76},
  number = {Supplement_1},
  pages = {S97--S105},
  doi = {10.1093/cid/ciad044}
}
Kostenlos starten →